The FDA approved lisdexamfetamine, a generic version of Vyvanse, in August 2024, but it quickly fell into shortage by early 2024. Despite the shortage
The FDA approved lisdexamfetamine, a Vyvanse generic, in August 2024. Lisdexamfetamine, along with many other ADHD medications, is currently also in shortage.
ADHD Medication Shortages (July 2024). There is currently a UK-wide shortage Lisdexamfetamine. Elva, 40, 50, mg capsules; Elvanse
Reason for the Shortage Alvogen has lisdexamfetamine capsules on shortage due to an issue with the active ingredient. Amneal has lisdexamfetamine capsules on
The FDA approved lisdexamfetamine, a Vyvanse generic, in August 2024. Lisdexamfetamine, along with many other ADHD medications, is currently also in shortage.
United States to provide shortages of lisdexamfetamine products with more shortages predicted for various strengths through April 2024.
The FDA approved lisdexamfetamine, a generic version of Vyvanse, in August 2024, but it quickly fell into shortage by early 2024. Despite the shortage
Reason for the Shortage Alvogen has lisdexamfetamine capsules on shortage due to an issue with the active ingredient. Amneal has lisdexamfetamine capsules on
As there is a significant shortage of In February 2024, the FDA approved the use of the stimulant lisdexamfetamine dimesylate
Comments